About Aradigm Corporation

Focuses on the development and commercialization of drugs

At the moment the company generates 4M USD in revenues.

On its last earning announcement, the company reported a loss of -1.09$ per share.

The book value per share is -1.32$

Aradigm Corporation website


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
4M - -12M -279.80% -16M -1.09 - - 15M -1.32 -17M - -17M